About
Biopharma professor with senior global roles at AstraZeneca and Almirall and various biotech companies, focused on respiratory, immunology and cancer. Currently Chairman of Aqilion AB and CMO at Galecto Inc. Joined XGEN in 2023.
Experience
- XGEN VENTURE LIFE SCIENCE FUNDVenture Partnercurrent2023 — presentMilan
- AQILION ABChairman of the Boardcurrent2022 — presentSkåne County, Sweden
- ALKBoard Member of ALKcurrent2021 — presentCopenhagen, Capital Region, Denmark
- Vicore Pharma ABSenior strategic Advisorcurrent2026 — presentSweden
- Cellevate ABBoard Of Directors2019 — 2025Lund
- Galecto, Inc.Chief Medical Officer2020 — 2023Copenhagen, Capital Region, Denmark
- Faculty of Medicine, Gothenburg UniversityProfessor in Innovation and Entrepeneurship2019 — 2023Gothenburg University, Sweden
- eTheRNA immunotherapiesChief Medical Officer at eTheRNA Immunotherapies2018 — 2020Belgium
- ASLAN PharmaceuticalsChief Medical Officer2016 — 2019Singapore
- ASLAN PharmaceuticalsChief Scientific Officer2015 — 2016Singapore
- AlmirallChief Scientific Officer, Executive Director, Research and Development, Member of the Board of Direc2011 — 2015Barcelona, Spain
- AstraZeneca R&DVP and Head Clinical Division, AstraZeneca Japan2009 — 2011
- AstraZenecaGlobal Therapy Area Clinical VP RITA2004 — 2009
- AstraZenecaGlobal Therapy Area Medical Director2001 — 2004
- AstraZenecaDirector Clinical Science2000 — 2001
- AstraDracoDirector Drug Safety and Epidemiology1991 — 2000
- Lund UniversityConsultant1987 — 1991
Education
- INSEADAMP, Advanced Management Program2009
- Lund UniversityDoctor of Medicine - MD, Medicine
- Lund UniversityPhD, Protease inhibitor deficiency1986 — 1991
- Lunds universitetMD, specialist in Internal Medicine and Gastroenterology1974 — 1986
- Lund UniversityDoctor of Philosophy - PhD
Skills & more
Project Management16Leadership32Continuous Improvement10Interpersonal Communication Abilities6Clinical Development99Pharmaceutical Industry99Clinical Trials87Clinical Research81Regulatory Affairs18Lifesciences16Drug Discovery33Biotechnology35
+12 more
Drug DevelopmentR&DCROMedical DevicesPharmaceuticsCTMSTechnology TransferHealthcareClinical Trial Management System (CTMS)Product LaunchMedicineBiochemistryLanguages English · German · Spanish
From Bertil's professional profile.
Same school
Also attended INSEAD668
Patrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMahesha SubramaniamHead of Client Relations at Golden Gate VenturesElena PantaziPartner & Head of Platform at Northzone
+ 662 more
Shared employers
Also worked at AQILION AB1
Also worked at ALK1
Also worked at Galecto, Inc.3
Also worked at eTheRNA immunotherapies2
Colleagues at XGEN Venture
Bastiaan van der Baan
Venture Partner at XGEN Venture
Bianca Benatti
Jr. Analyst at XGEN Venture
Carlotta Marchese
Regulatory and Corporate Affairs Specialist at XGEN Venture
Daniele Scarinci
Founder and Managing Partner at XGEN Venture
Federica Draghi
Founder and Managing Partner at XGEN Venture
Gokhan Batur
Venture Partner at XGEN Venture
Graziano Piredda
Sr. Analyst at XGEN Venture
Keith Dawkins
Venture Partner at XGEN Venture


.jpg)


%20(1).png)





















